391 related articles for article (PubMed ID: 19735553)
41. LncSNHG16 promotes proliferation and migration of osteosarcoma cells by targeting microRNA-146a-5p.
Zheng SN; Ge DW; Tang J; Yang J; Yan JW; Qiu JJ; Yin ZW; Ni Y; Zhao L; Chen X; Yang L
Eur Rev Med Pharmacol Sci; 2019 Jan; 23(1):96-104. PubMed ID: 30657551
[TBL] [Abstract][Full Text] [Related]
42. Integrated Genome-Wide Methylation and Expression Analyses Reveal Key Regulators in Osteosarcoma.
Wang F; Qin G; Liu J; Wang X; Ye B
Comput Math Methods Med; 2020; 2020():7067649. PubMed ID: 32855654
[TBL] [Abstract][Full Text] [Related]
43. Gene expression array profile of human osteosarcoma.
Leonard P; Sharp T; Henderson S; Hewitt D; Pringle J; Sandison A; Goodship A; Whelan J; Boshoff C
Br J Cancer; 2003 Dec; 89(12):2284-8. PubMed ID: 14676807
[TBL] [Abstract][Full Text] [Related]
44. Anoikis-resistant subpopulations of human osteosarcoma display significant chemoresistance and are sensitive to targeted epigenetic therapies predicted by expression profiling.
Foley JM; Scholten DJ; Monks NR; Cherba D; Monsma DJ; Davidson P; Dylewski D; Dykema K; Winn ME; Steensma MR
J Transl Med; 2015 Apr; 13():110. PubMed ID: 25889105
[TBL] [Abstract][Full Text] [Related]
45. Identification of Differentially Expressed Genes under the Regulation of Transcription Factors in Osteosarcoma.
Liu Y; Guan J; Chen X
Pathol Oncol Res; 2019 Jul; 25(3):1091-1102. PubMed ID: 30411296
[TBL] [Abstract][Full Text] [Related]
46. miR-21 predicts poor prognosis in patients with osteosarcoma.
Ren X; Shen Y; Zheng S; Liu J; Jiang X
Br J Biomed Sci; 2016 Oct; 73(4):158-162. PubMed ID: 27922432
[TBL] [Abstract][Full Text] [Related]
47. A systems biology approach to identify molecular pathways altered by HDAC inhibition in osteosarcoma.
Wittenburg LA; Ptitsyn AA; Thamm DH
J Cell Biochem; 2012 Mar; 113(3):773-83. PubMed ID: 21976144
[TBL] [Abstract][Full Text] [Related]
48. 12 Survival-related differentially expressed genes based on the TARGET-osteosarcoma database.
Rothzerg E; Xu J; Wood D; Kõks S
Exp Biol Med (Maywood); 2021 Oct; 246(19):2072-2081. PubMed ID: 33926256
[TBL] [Abstract][Full Text] [Related]
49. MAPK pathways regulation by DUSP1 in the development of osteosarcoma: Potential markers and therapeutic targets.
Lopes LJS; Tesser-Gamba F; Petrilli AS; de Seixas Alves MT; Garcia-Filho RJ; Toledo SRC
Mol Carcinog; 2017 Jun; 56(6):1630-1641. PubMed ID: 28112450
[TBL] [Abstract][Full Text] [Related]
50. miR-541 serves as a prognostic biomarker of osteosarcoma and its regulatory effect on tumor cell proliferation, migration and invasion by targeting TGIF2.
Liu C; Yi X
Diagn Pathol; 2020 Jul; 15(1):96. PubMed ID: 32709240
[TBL] [Abstract][Full Text] [Related]
51. Identification of a novel miRNA-target gene regulatory network in osteosarcoma by integrating transcriptome analysis.
He C; Gao H; Fan X; Wang M; Liu W; Huang W; Yang Y
Int J Clin Exp Pathol; 2015; 8(7):8348-57. PubMed ID: 26339404
[TBL] [Abstract][Full Text] [Related]
52. Identification of Pathogenic Genes and Transcription Factors in Osteosarcoma.
Yang C; Huang D; Ma C; Ren J; Fu L; Cheng C; Li B; Shi X
Pathol Oncol Res; 2020 Apr; 26(2):1041-1048. PubMed ID: 30982140
[TBL] [Abstract][Full Text] [Related]
53. A systems biology approach reveals common metastatic pathways in osteosarcoma.
Flores RJ; Li Y; Yu A; Shen J; Rao PH; Lau SS; Vannucci M; Lau CC; Man TK
BMC Syst Biol; 2012 May; 6():50. PubMed ID: 22640921
[TBL] [Abstract][Full Text] [Related]
54. MiR-455-3p downregulation facilitates cell proliferation and invasion and predicts poor prognosis of osteosarcoma.
Yi X; Wang Y; Xu S
J Orthop Surg Res; 2020 Oct; 15(1):454. PubMed ID: 33008443
[TBL] [Abstract][Full Text] [Related]
55. Exploring the key genes and pathways of side population cells in human osteosarcoma using gene expression array analysis.
Ren YM; Duan YH; Sun YB; Yang T; Zhao WJ; Zhang DL; Tian ZW; Tian MQ
J Orthop Surg Res; 2018 Jun; 13(1):153. PubMed ID: 29921292
[TBL] [Abstract][Full Text] [Related]
56. S-adenosylmethionine blocks osteosarcoma cells proliferation and invasion in vitro and tumor metastasis in vivo: therapeutic and diagnostic clinical applications.
Parashar S; Cheishvili D; Arakelian A; Hussain Z; Tanvir I; Khan HA; Szyf M; Rabbani SA
Cancer Med; 2015 May; 4(5):732-44. PubMed ID: 25619880
[TBL] [Abstract][Full Text] [Related]
57. A comparison between genetic portraits of normal osteoblasts and osteosarcoma cell lines.
Palmieri A; Pezzetti F; Brunelli G; Ilaria Z; Carinci F
Indian J Dent Res; 2009; 20(1):52-9. PubMed ID: 19336861
[TBL] [Abstract][Full Text] [Related]
58. Establishment of immune prognostic signature and analysis of prospective molecular mechanisms in childhood osteosarcoma patients.
Zhang Z; Liu C; Liang T; Yu C; Qin Z; Zhou X; Xue J; Zeng H; Lu Z; Xu G; Wang Z; Chen J; Jiang J; Zhan X
Medicine (Baltimore); 2020 Nov; 99(46):e23251. PubMed ID: 33181717
[TBL] [Abstract][Full Text] [Related]
59. Logistic regression analysis for the identification of the metastasis-associated signaling pathways of osteosarcoma.
Liu Y; Sun W; Ma X; Hao Y; Liu G; Hu X; Shang H; Wu P; Zhao Z; Liu W
Int J Mol Med; 2018 Mar; 41(3):1233-1244. PubMed ID: 29328361
[TBL] [Abstract][Full Text] [Related]
60. Transcriptional profiling of canine osteosarcoma identifies prognostic gene expression signatures with translational value for humans.
Mannheimer JD; Tawa G; Gerhold D; Braisted J; Sayers CM; McEachron TA; Meltzer P; Mazcko C; Beck JA; LeBlanc AK
Commun Biol; 2023 Aug; 6(1):856. PubMed ID: 37591946
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
